CD274 and neoplasm: Many tumour cells express PD‐L1, and inhibition of the interaction between PD‐1 and PD‐L1 by ICIs such as anti‐PD‐1 or PD‐L1 antibodies enhances cytotoxic T‐cell responses through engagement with MHC class I antigens [49].